Xiancheng Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xiancheng Chen has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Wenkui Yu
Department of Critical Care Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China
3 shared publications Asly Chua An Wen
Department of Pharmaceutics, China Pharmaceutical University, Jiangsu, PR China
1 shared publication- Beiyuan Zhang
Department of Critical Care Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210008, China
1 shared publication - Dacheng Wang
Department of Intensive Care Unit, The Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing 210008, China
1 shared publication - Huanhuan Wang
Department of Critical Care Medicine, Nanjing Drum Tower Hospital, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, China
1 shared publication - Jiali Liu
Department of Intensive Care Unit, The Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing 210008, China
1 shared publication
Latest Publications
- 28 September 2026
- Published by Springer Nature in Pharmaceutical Research
- Vol. 43 (10) , 3469-3504
Engineering Oral Nanoparticles: Navigating Biological Barriers in the Gastrointestinal Tract
- 28 September 2026
- Published by Springer Nature in Pharmaceutical Research
- Vol. 43 (10) , 3469-3504
Engineering Oral Nanoparticles: Navigating Biological Barriers in the Gastrointestinal Tract
- Open Access
- 16 April 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (8) , 3038
Early Prediction and Prognostic Value of Chronic Critical Illness and Persistent Inflammation, Immunosuppression, and Catabolism Syndrome in Patients with Severe Acute Pancreatitis: A Retrospective Cohort Study
Background: Patients with severe acute pancreatitis (SAP) are at high risk for developing chronic critical illness (CCI) and persistent inflammation, immunosuppression, and catabolism syndrome (PICS). However, the specific risk factors and prognostic implications of these conditions remain unclear. Methods: This single-center retrospective cohort study enrolled adult patients with SAP requiring ICU stay > 14 days. Least absolute shrinkage and selection operator (LASSO) regression was used to select risk factors, followed by multivariable logistic regression to identify independent predictors for CCI and PICS. Discriminative ability of early severity scores was assessed using the area under the curve (AUC) and compared via the DeLong’s test. Kaplan–Meier and Cox regression evaluated in-hospital and 90-day mortality differences. Results: Among 156 SAP patients, 60 (38.5%) developed CCI, 38 (24.4%) progressed to PICS, and 32 (20.5%) met both criteria. After multivariable adjustment and sensitivity analyses, the computed tomography severity index (CTSI) emerged as an independent risk factor for both CCI (odds ratio [OR]: 1.40, 95% confidence interval [CI] 1.18–1.66) and PICS (OR: 1.56, 95% CI 1.29–1.89), with AUC values of 0.747 and 0.804, respectively. Significant differences in both the in-hospital and 90-day mortality rates were observed among the three groups (p < 0.001). The patients meeting both CCI and PICS criteria exhibited markedly increased risks of in-hospital (hazard ratio [HR]: 7.80, 95% CI 1.53–39.77; p = 0.013) and 90-day mortality (HR: 3.11, 95% CI 1.08–8.95; p = 0.035) after the multivariable adjustment. Conclusions: CTSI is an independent risk factor for CCI and PICS in patients with SAP. Both CCI and PICS were associated with a heightened risk of adverse outcomes. Future studies are warranted to explore the clinical characteristics and targeted interventions for this high-risk subgroup.
- 16 April 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (8) , 3038
Open AccessEarly Prediction and Prognostic Value of Chronic Critical Illness and Persistent Inflammation, Immunosuppression, and Catabolism Syndrome in Patients with Severe Acute Pancreatitis: A Retrospective Cohort Study
Background: Patients with severe acute pancreatitis (SAP) are at high risk for developing chronic critical illness (CCI) and persistent inflammation, immunosuppression, and catabolism syndrome (PICS). However, the specific risk factors and prognostic implications of these conditions remain unclear. Methods: This single-center retrospective cohort study enrolled adult patients with SAP requiring ICU stay > 14 days. Least absolute shrinkage and selection operator (LASSO) regression was used to select risk factors, followed by multivariable logistic regression to identify independent predictors for CCI and PICS. Discriminative ability of early severity scores was assessed using the area under the curve (AUC) and compared via the DeLong’s test. Kaplan–Meier and Cox regression evaluated in-hospital and 90-day mortality differences. Results: Among 156 SAP patients, 60 (38.5%) developed CCI, 38 (24.4%) progressed to PICS, and 32 (20.5%) met both criteria. After multivariable adjustment and sensitivity analyses, the computed tomography severity index (CTSI) emerged as an independent risk factor for both CCI (odds ratio [OR]: 1.40, 95% confidence interval [CI] 1.18–1.66) and PICS (OR: 1.56, 95% CI 1.29–1.89), with AUC values of 0.747 and 0.804, respectively. Significant differences in both the in-hospital and 90-day mortality rates were observed among the three groups (p < 0.001). The patients meeting both CCI and PICS criteria exhibited markedly increased risks of in-hospital (hazard ratio [HR]: 7.80, 95% CI 1.53–39.77; p = 0.013) and 90-day mortality (HR: 3.11, 95% CI 1.08–8.95; p = 0.035) after the multivariable adjustment. Conclusions: CTSI is an independent risk factor for CCI and PICS in patients with SAP. Both CCI and PICS were associated with a heightened risk of adverse outcomes. Future studies are warranted to explore the clinical characteristics and targeted interventions for this high-risk subgroup.
- 18 February 2026
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 115 (2) , 117322
Admission clinical features associated with disease severity in psittacosis pneumonia: A retrospective study
- 18 February 2026
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 115 (2) , 117322
Admission clinical features associated with disease severity in psittacosis pneumonia: A retrospective study
- Open Access
- 28 January 2023
- Published by MDPI AG in Metabolites
- Vol. 13 (2) , 194
Akkermansia muciniphila Alleviates Persistent Inflammation, Immunosuppression, and Catabolism Syndrome in Mice
Many patients in intensive care units, especially the elderly, suffer from chronic critical illness and exhibit a new pathophysiological phenotype: persistent inflammation, immunosuppression, and catabolism syndrome (PICS). Most patients with PICS have a constellation of digestive-system symptoms and gut failure. Akkermansia muciniphila (Akk) is a commensal gut bacterium that reduces inflammation, balances immune responses, modulates energy metabolism, and supports gut health. This study investigated the protective effects and underlying mechanisms of live and pasteurized Akk in treating PICS in a mouse model. PICS was induced on day 14 after performing cecal ligation and puncture (CLP) on day 1 and administrating lipopolysaccharide on day 11. Pasteurized or live Akk, or phosphate-buffered saline was administered twice daily by oral gavage for 7 days. Both live and pasteurized Akk attenuated PICS, as evidenced by reduced weight loss, and a reduction in symptoms and serum cytokine/chemokine levels. Liver and intestinal injuries were mitigated, and intestinal barrier integrity improved with Akk administration. Analysis of 16S rRNA amplicon sequences showed that Akk induced significant intestinal microbiota alterations, including increased abundance of Akk, Muribaculaceae, Parabacterbides goldsteinii, and decreased abundance of Escherichia_Shigella and Enterobacteriaceae. Collectively, Akk alleviates PICS by enhancing gut barrier function and reshaped the microbial community.
- 28 January 2023
- Published by MDPI AG in Metabolites
- Vol. 13 (2) , 194
Open AccessAkkermansia muciniphila Alleviates Persistent Inflammation, Immunosuppression, and Catabolism Syndrome in Mice
Many patients in intensive care units, especially the elderly, suffer from chronic critical illness and exhibit a new pathophysiological phenotype: persistent inflammation, immunosuppression, and catabolism syndrome (PICS). Most patients with PICS have a constellation of digestive-system symptoms and gut failure. Akkermansia muciniphila (Akk) is a commensal gut bacterium that reduces inflammation, balances immune responses, modulates energy metabolism, and supports gut health. This study investigated the protective effects and underlying mechanisms of live and pasteurized Akk in treating PICS in a mouse model. PICS was induced on day 14 after performing cecal ligation and puncture (CLP) on day 1 and administrating lipopolysaccharide on day 11. Pasteurized or live Akk, or phosphate-buffered saline was administered twice daily by oral gavage for 7 days. Both live and pasteurized Akk attenuated PICS, as evidenced by reduced weight loss, and a reduction in symptoms and serum cytokine/chemokine levels. Liver and intestinal injuries were mitigated, and intestinal barrier integrity improved with Akk administration. Analysis of 16S rRNA amplicon sequences showed that Akk induced significant intestinal microbiota alterations, including increased abundance of Akk, Muribaculaceae, Parabacterbides goldsteinii, and decreased abundance of Escherichia_Shigella and Enterobacteriaceae. Collectively, Akk alleviates PICS by enhancing gut barrier function and reshaped the microbial community.